Contact UsQuotation
Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Proceed to checkoutContinue shopping
TOPBioactivityChemical infoStorage&SolubilityCalculator

ROR1-IN-4

😃Good
Catalog No. T212080

ROR1-IN-4 is a selective inhibitor of ROR1 with a dissociation constant (Kd) of 52 nM. It exhibits potent antiproliferative activity in the triple-negative breast cancer (TNBC) cell line MDA-MB-231, with an IC50 of 75 nM. ROR1-IN-4 reduces colony formation, induces apoptosis (apoptosis), and inhibits phosphorylation of ROR1(Tyr786) in these cells. Additionally, ROR1-IN-4 demonstrates significant antitumor efficacy in nude mice bearing subcutaneous MDA-MB-231 xenograft tumors. This compound is applicable for research related to TNBC.

ROR1-IN-4

ROR1-IN-4

😃Good
Catalog No. T212080
ROR1-IN-4 is a selective inhibitor of ROR1 with a dissociation constant (Kd) of 52 nM. It exhibits potent antiproliferative activity in the triple-negative breast cancer (TNBC) cell line MDA-MB-231, with an IC50 of 75 nM. ROR1-IN-4 reduces colony formation, induces apoptosis (apoptosis), and inhibits phosphorylation of ROR1(Tyr786) in these cells. Additionally, ROR1-IN-4 demonstrates significant antitumor efficacy in nude mice bearing subcutaneous MDA-MB-231 xenograft tumors. This compound is applicable for research related to TNBC.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
ROR1-IN-4 is a selective inhibitor of ROR1 with a dissociation constant (Kd) of 52 nM. It exhibits potent antiproliferative activity in the triple-negative breast cancer (TNBC) cell line MDA-MB-231, with an IC50 of 75 nM. ROR1-IN-4 reduces colony formation, induces apoptosis (apoptosis), and inhibits phosphorylation of ROR1(Tyr786) in these cells. Additionally, ROR1-IN-4 demonstrates significant antitumor efficacy in nude mice bearing subcutaneous MDA-MB-231 xenograft tumors. This compound is applicable for research related to TNBC.
Targets&IC50
ROR1:0.052 μM (Kd)
In vitro
ROR1-IN-4 (Compound 59) exhibits potent antiproliferative activity in triple-negative breast cancer (TNBC) cell line MDA-MB-231, with an IC50 of 0.075 μM, whereas it shows no significant antiproliferative effect in non-TNBC cell lines MCF-7 (IC50 > 10 μM) and HEK-293T (IC50 = 9.72 μM). Additionally, ROR1-IN-4 (0.1-3 μM, 48 h) induces apoptosis and suppresses the phosphorylation of ROR1 (Tyr786) in MDA-MB-231 cells. Furthermore, ROR1-IN-4 (0.1-1 μM, 14 days) reduces colony formation in MDA-MB-231 cells.
In vivo
Compound ROR1-IN-4 (Compound 59), administered intraperitoneally at doses of 10-20 mg/kg every other day for 30 days, demonstrates excellent antitumor activity in nude mice with MDA-MB-231 subcutaneous xenograft tumors. Additionally, ROR1-IN-4 at 10 mg/kg, delivered intraperitoneally every other day for 45 days, exhibits strong inhibition of tumor growth and metastasis in nude mice with MDA-MB-231-Luc orthotopic breast xenograft tumors.
Chemical Properties
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy ROR1-IN-4 | purchase ROR1-IN-4 | ROR1-IN-4 cost | order ROR1-IN-4 | ROR1-IN-4 in vivo | ROR1-IN-4 in vitro
TargetMol | Logo

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.